Crosstalk between dendritic cells and T lymphocytes during atherogenesis: Focus on antigen presentation and break of tolerance
- PMID: 35966516
- PMCID: PMC9365967
- DOI: 10.3389/fcvm.2022.934314
Crosstalk between dendritic cells and T lymphocytes during atherogenesis: Focus on antigen presentation and break of tolerance
Abstract
Atherosclerosis is a chronic disease resulting from an impaired lipid and immune homeostasis, where the interaction between innate and adaptive immune cells leads to the promotion of atherosclerosis-associated immune-inflammatory response. Emerging evidence has suggested that this response presents similarities to the reactivity of effector immune cells toward self-epitopes, often as a consequence of a break of tolerance. In this context, dendritic cells, a heterogeneous population of antigen presenting cells, play a key role in instructing effector T cells to react against foreign antigens and T regulatory cells to maintain tolerance against self-antigens and/or to patrol for self-reactive effector T cells. Alterations in this delicate balance appears to contribute to atherogenesis. The aim of this review is to discuss different DC subsets, and their role in atherosclerosis as well as in T cell polarization. Moreover, we will discuss how loss of T cell tolerogenic phenotype participates to the immune-inflammatory response associated to atherosclerosis and how a better understanding of these mechanisms might result in designing immunomodulatory therapies targeting DC-T cell crosstalk for the treatment of atherosclerosis-related inflammation.
Keywords: ApoB; T cell priming; atherosclerosis; break of tolerance; dendritic cells.
Copyright © 2022 Bellini, Bonacina and Norata.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures

Similar articles
-
The benefits of diversity: heterogenous DC populations allow for both immunity and tolerance.J Theor Biol. 2014 Sep 21;357:86-102. doi: 10.1016/j.jtbi.2014.04.034. Epub 2014 May 9. J Theor Biol. 2014. PMID: 24816181
-
Dendritic cells in atherogenesis: possible novel targets for prevention of atherosclerosis.J Atheroscler Thromb. 2012;19(11):953-61. doi: 10.5551/jat.14134. Epub 2012 Aug 9. J Atheroscler Thromb. 2012. PMID: 22878702 Review.
-
Functional crosstalk between dendritic cells and Foxp3(+) regulatory T cells in the maintenance of immune tolerance.Front Immunol. 2012 Jun 22;3:165. doi: 10.3389/fimmu.2012.00165. eCollection 2012. Front Immunol. 2012. PMID: 22737152 Free PMC article.
-
Myeloid dendritic cells: Development, functions, and role in atherosclerotic inflammation.Immunobiology. 2015 Jun;220(6):833-44. doi: 10.1016/j.imbio.2014.12.010. Epub 2015 Jan 5. Immunobiology. 2015. PMID: 25595536 Review.
-
Current advances in understanding of immunopathology of atherosclerosis.Virchows Arch. 2011 Feb;458(2):117-23. doi: 10.1007/s00428-010-1006-5. Epub 2010 Nov 11. Virchows Arch. 2011. PMID: 21069384 Review.
Cited by
-
Cells in Atherosclerosis: Focus on Cellular Senescence from Basic Science to Clinical Practice.Int J Mol Sci. 2023 Dec 5;24(24):17129. doi: 10.3390/ijms242417129. Int J Mol Sci. 2023. PMID: 38138958 Free PMC article. Review.
-
Autoantibodies to Oxidatively Modified Peptide: Potential Clinical Application in Coronary Artery Disease.Diagnostics (Basel). 2022 Sep 20;12(10):2269. doi: 10.3390/diagnostics12102269. Diagnostics (Basel). 2022. PMID: 36291959 Free PMC article.
-
Methazolamide Can Treat Atherosclerosis by Increasing Immunosuppressive Cells and Decreasing Expressions of Genes Related to Proinflammation, Calcification, and Tissue Remodeling.J Immunol Res. 2024 Jul 23;2024:5009637. doi: 10.1155/2024/5009637. eCollection 2024. J Immunol Res. 2024. PMID: 39081633 Free PMC article.
-
Dendritic cell marker Clec4a4 deficiency limits atherosclerosis progression.Atheroscler Plus. 2022 Dec 17;51:8-12. doi: 10.1016/j.athplu.2022.12.001. eCollection 2023 Mar. Atheroscler Plus. 2022. PMID: 36969702 Free PMC article.
-
Oxidized Low-Density Lipoprotein and Its Role in Immunometabolism.Int J Mol Sci. 2024 Oct 23;25(21):11386. doi: 10.3390/ijms252111386. Int J Mol Sci. 2024. PMID: 39518939 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous